Shares of Immucor BLUD are lower on the session by 0.19%, trading at $26.60.
Overall call volume is now running at 4.08x the daily average, with 2% of all calls traded being purchases on the offer. 1,216 contracts have traded on the session so far.
Immucor, Inc. develops, manufactures and sells a line of reagents and automated systems that detect and identify certain properties of the cell and serum components of human blood for the purpose of blood transfusion.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in